Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Lakewood-Amedex Biotherapeutics, Inc. LABT

Full chart Compare
Set alert

Price alert · LABT

All alert types
0.54 USD +0.35 (+182.45%)

At closeNov 5, 2026, 7:59 PM EST

0.51 -0.03 -5.68%

After hours · Nov 5, 7:59 PM ET

0.3701 Day range 0.96
0.19 52-week range 86.50
YTD
-99.38%
1 year
-99.38%

Revenue & Expenses

Revenue → Gross Profit: $36.17MGross Profit → Net Income: $176.00KGross Profit → Selling, General & Admin: $23.13MGross Profit → Research & Development: $2.34MRevenue → Cost of Revenue: $54.34MGross Profit → Other Operating Expenses: $4.46MGross Profit → Interest Expense: $4.12MGross Profit → Other Expenses: $1.17MGross Profit → Income Tax: $776.00KGross Profit$36.17MCost of Revenue$54.34MNet Income$176.00KSelling, General & Admin$23.13MResearch & Development$2.34MOther Operating Expenses$4.46MInterest Expense$4.12MOther Expenses$1.17MIncome Tax$776.00KRevenue$90.51M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
LABT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2000 Mar 31, 2000FY 1999 Mar 31, 1999
-3.77M-4.03M-8.64M6.24M-2.53M
-3.85M-4.86M-8.28M176.00K-4.94M
-8.40-9.90-12.20—-1.98

Balance sheet

Full balance sheet How to read it
LABT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2000 Mar 31, 2000FY 1999 Mar 31, 1999
236.40K681.10K2.53M1.37M768.00K
481.60K1.07M6.89M63.27M46.97M
2.45M660.97K2.34M55.16M42.27M
1.66M272.86K578.88K42.41M30.09M
-1.96M409.61K4.56M8.11M4.70M

Cash flow

Full cash flow How to read it
LABT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2000 Mar 31, 2000FY 1999 Mar 31, 1999
-1.94M-5.72M-6.82M3.37M3.63M
1.50M-50.00K011.64M-5.98M
-444.70K-1.85M-10.60M605.00K-220.00K